Gratus Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$519K Hold
1,343
0.07% 89
2026
Q1
$393K Sell
1,343
-83
-6% -$27.3K 0.06% 104
2025
Q4
$500K Sell
1,426
-200
-12% -$67.6K 0.07% 89
2025
Q3
$525K Sell
1,626
-70
-4% -$21.8K 0.07% 96
2025
Q2
$660K Hold
1,696
0.1% 76
2025
Q1
$738K Sell
1,696
-47
-3% -$18.9K 0.12% 74
2024
Q4
$643K Sell
1,743
-24
-1% -$10K 0.1% 79
2024
Q3
$869K Sell
1,767
-154
-8% -$82.3K 0.14% 67
2024
Q2
$961K Sell
1,921
-114
-6% -$60.3K 0.17% 57
2024
Q1
$1.07M Hold
2,035
0.2% 48
2023
Q4
$960K Buy
+2,035
New +$941K 0.19% 55

Other funds holding ELV

Gratus Wealth Advisors's ELV Position: Q2 2026 in Review

Gratus Wealth Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 1,343 shares worth $519K. The position accounts for 0.07% of the portfolio, ranked #89.

Gratus Wealth Advisors first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.07M in Q1 2024. 594 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Gratus Wealth Advisors held 1,343 shares of Elevance Health worth $519K as of Q2 2026.
  • Gratus Wealth Advisors left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.07% of Gratus Wealth Advisors's portfolio in Q2 2026, its #89 holding.
  • Gratus Wealth Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Gratus Wealth Advisors's Elevance Health position peaked at $1.07M in Q1 2024.
  • 594 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Gratus Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.